Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
135.8 EUR | -0.07% |
|
-1.43% | -4.45% |
02/07 | J&J: promising results in multiple myeloma | CF |
02/07 | Johnson & Johnson Says Interim Analysis of Blood Cancer Therapy Study Show Promise | MT |
- Stock Market
- Equities
- JNJ Stock
- JNJ Stock
- News Johnson & Johnson
- MarketScreener Strategies